Synthesis and evaluation of novel benzylphthalazine derivatives as hedgehog signaling pathway inhibitors

Bioorg Med Chem Lett. 2016 Jul 1;26(13):3048-3051. doi: 10.1016/j.bmcl.2016.05.009. Epub 2016 May 5.

Abstract

We report herein the design and synthesis of a series of novel benzylphthalazine derivatives as hedgehog signaling pathway inhibitors. Gli-luciferase assay demonstrated that changing piperazine ring of Anta XV to different four, five or six-membered heterocyclic building blocks afforded significant influences on Hh pathway inhibition. In particular, compound 10e with piperidin-4-amine moiety was found to possess 12-fold higher Hh inhibitory activities comparing to the lead compound in vitro. In vivo efficacy of 10e in a ptch(+/-)p53(-/-) mouse medulloblastoma allograft model also indicated encouraging results.

Keywords: Anti-tumor agents; Benzylphthalazines; Hedgehog signaling pathway; Inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology
  • Hedgehog Proteins / metabolism*
  • Mice
  • NIH 3T3 Cells
  • Phthalazines / chemical synthesis
  • Phthalazines / pharmacokinetics
  • Phthalazines / pharmacology*
  • Piperazines / pharmacology
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Structure-Activity Relationship

Substances

  • 2-(6-((1-(4-benzylphthalazin-1-yl)piperidin-4-yl)amino)pyridin-3-yl)propan-2-ol
  • Anta XV
  • Antineoplastic Agents
  • Hedgehog Proteins
  • Phthalazines
  • Piperazines